GANNON STEVEN bought XENE
June 3, 2026 · Form 4 insider transaction
GANNON STEVEN bought 1,593 shares of Xenon Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,593
Price
$0.00
Total value
N/A
InsiderGANNON STEVEN
RoleDirector
SecurityRestricted Share Units
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 3, 2026
Shares owned after1,593
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.